Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2017

Sep 7, 2017

30786_dirs_2017-09-06_04bfd220-9f18-48de-9711-cef668f78b51.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-05

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-05 Restricted Stock Units $0 A 13000 Acquired Bio-Rad A Common Stock (13000) Direct
2017-09-05 Non-Qualified Stock Option (right to buy) $215.98 A 13000 Acquired 2027-09-05 Bio-Rad A Common Stock (13000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 12664 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 236451 Direct

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F4: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F5: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.